Real-world outcomes of elderly patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with chimeric antigen receptor T-cell (CAR-T) therapy.
暂无分享,去创建一个
C. Jacobson | A. Kittai | J. Chipman | L. Nastoupil | M. Kamdar | A. Waller | N. Denlinger | Anna Saucier | B. Hu | J. Spradley | L. Fitzgerald